Preoperative steroids for hearing preservation cochlear implantation: A review

References

• Alzamil, K.S., Linthicum FH Jr. 2000. Extraneous round window membranes and plugs: possible effect on intratympanic therapy. Annals of Otology, Rhinology & Laryngology, 109: 30–32. doi: 10.1177/000348940010900105
   PubMed Web of Science ®Google Scholar
• Ariyasu, L., Byl, F.M., Sprague, M.S., Adour, K.K. 1990. The beneficial effect of methylprednisolone in acute vestibular vertigo. Archives of Otolaryngology – Head and Neck Surgery, 116(6): 700–703. doi: 10.1001/archotol.1990.01870060058010
   PubMedGoogle Scholar
• Arnoldner, C., Gstoettner, W., Riss, D., Wagenblast, J., Honeder, C., Blineder, et al. 2011. Residual hearing preservation using the suprameatal approach for cochlear implantation. Wiener klinische Wochenschrift, 123(19–20): 599–602. doi: 10.1007/s00508-011-0043-7
   PubMed Web of Science ®Google Scholar
• Ballard, P.L., Baxter, J.D., Higgins, S.J., Rousseau, G.G., Tomkins, G.M. 1974. General presence of glucocorticoid receptors in mammalian tissues. Endocrinology, 94(4): 998–1002. doi: 10.1210/endo-94-4-998
   PubMed Web of Science ®Google Scholar
• Barrs, D.M. 2004. Intratympanic injections of dexamethasone for long-term control of Vertigo. The Laryngoscope, 114(11): 1910–1914. doi: 10.1097/01.mlg.0000147919.89357.16
   PubMed Web of Science ®Google Scholar
• Bird, P.A., Murray, D.P., Zhang, M., Begg, E.J. 2011. Intratympanic versus intravenous delivery of dexamethasone and dexamethasone sodium phosphate to cochlear perilymph. Otology & Neurotology, 32(6): 933–936. doi: 10.1097/MAO.0b013e3182255933
   PubMed Web of Science ®Google Scholar
• Boldyreff, B., Wehling, M. 2003. Rapid aldosterone actions: from the membrane to signaling cascades to gene transcription and physiological effects. The Journal of Steroid Biochemistry and Molecular Biology, 85(2–5): 375–381. doi: 10.1016/S0960-0760(03)00202-4
   PubMed Web of Science ®Google Scholar
• Brown, R.F., Hullar, T.E., Cadieux, J.H., Chole, R.A. 2010. Residual hearing preservation after pediatric cochlear implantation. Otology & Neurotology, 31(8): 1221–1226. doi: 10.1097/MAO.0b013e3181f0c649
   PubMed Web of Science ®Google Scholar
• Bruce, I.A., Bates, J.E., Melling, C., Mawman, D., Green, K.M. 2011. Hearing preservation via a cochleostomy approach and deep insertion of a standard length cochlear implant electrode. Otology & Neurotology, 32(9): 1444–1447. doi: 10.1097/MAO.0b013e3182355824
   PubMed Web of Science ®Google Scholar
• Büchner, A., Schüssler, M., Battmer, R.D., Stöver, T., Lesinski-Schiedat, A., Lenarz, T. 2009. Impact of low-frequency hearing. Audiology and Neurotology, 14(Suppl. 1): 8–13.
   PubMed Web of Science ®Google Scholar
• Casani, A.P., Piaggi, P., Cerchiai, N., Seccia, V., Franceschini, S.S., Dallan, I. 2012. Intratympanic treatment of intractable unilateral Meniere disease: gentamicin or dexamethasone? A randomized controlled trial. Otolaryngology – Head and Neck Surgery, 146(3): 430–437. doi: 10.1177/0194599811429432
   PubMed Web of Science ®Google Scholar
• Chandrasekhar, S.S., Rubinstein, R.Y., Kwartler, J.A., Gatz, M., Connelly, P.E., Huang, E., et al. 2000. Dexamethasone pharmacokinetics in the inner ear: comparison of route of administration and use of facilitating agents. Otolaryngol Head Neck Surg, 122(4): 521–8.
   PubMed Web of Science ®Google Scholar
• Chang, A., Eastwood, H., Sly, D., James, D., Richardson, R., O'Leary, S. 2009. Factors influencing the efficacy of round window dexamethasone protection of residual hearing post-cochlear implant surgery. Hearing Research, 255(1–2): 67–72. 2009 Jan 12;1–8. doi: 10.1016/j.heares.2009.05.010
   PubMed Web of Science ®Google Scholar
• Ching, T.Y.C., Dillon, H., Byrne, D. 1998. Speech recognition of hearing-impaired listeners: prediction from audibility and the limited role of high-frequency amplification. The Journal of the Acoustical Society of America, 103: 1128–1140. doi: 10.1121/1.421224
   PubMed Web of Science ®Google Scholar
• Choi, C.H., Oghalai, J.S. 2005. Predicting the effect of post-implant cochlear fibrosis on residual hearing. Hearing Research, 205(1–2): 193–200. doi: 10.1016/j.heares.2005.03.018
   PubMed Web of Science ®Google Scholar
• Cifone, M.G., Migliorati, G., Parroni, R., Marchetti, C., Millimaggi, D., Santoni, A., et al. 1999. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood, 93(7): 2282–2296.
   PubMed Web of Science ®Google Scholar
• Clark, G.M., Pyman, B.C., Bailey, Q.R. 1979. The surgery for multiple-electrode cochlear implantations. The Journal of Laryngology & Otology, 93(3): 215–223. doi: 10.1017/S0022215100086977
   PubMed Web of Science ®Google Scholar
• Coco, A., Epp, S.B., Fallon, J.B., Xu, J., Millard, R.E., Shepherd, R.K. 2007. Does cochlear implantation and electrical stimulation affect residual hair cells and spiral ganglion neurons? Hearing Research, 225(1–2): 60–70. Epub 2006 Dec 15. doi: 10.1016/j.heares.2006.12.004
   PubMed Web of Science ®Google Scholar
• Connolly, T.M., Eastwood, H., Kel, G., Lisnichuk, H., Richardson, R., O'Leary, S. 2011. Pre-operative intravenous dexamethasone prevents auditory threshold shift in a guinea pig model of cochlear implantation. Audiology and Neurotology, 16(3): 137–144. doi: 10.1159/000314757
   PubMed Web of Science ®Google Scholar
• Cosetti, M.K., Friedmann, D.R., Zhu, B.Z., Heman-Ackah, S.E., Fang, Y., Keller, R.G., et al. 2013. The effects of residual hearing in traditional cochlear implant candidates after implantation with a conventional electrode. Otology & Neurotology, 34(3): 516–521. doi: 10.1097/MAO.0b013e3182785210
   PubMed Web of Science ®Google Scholar
• Curtis, J.R., Westfall, A.O., Allison, J., Bijlsma, J.W., Freeman, A., George, V., et al. 2006. Population-based assessment of adverse events associated with long-term glucocorticoid use. Arthritis & Rheumatism, 55(3): 420–426. doi: 10.1002/art.21984
   PubMed Web of Science ®Google Scholar
• Czock, D., Keller, F., Rasche, F.M., Häussler, U. 2005. Pharmacokinetics and pharmacodynamics of systemically administered glucocorticoids. Clinical Pharmacokinetics, 44(1): 61–98. doi: 10.2165/00003088-200544010-00003
   PubMed Web of Science ®Google Scholar
• De Ceulaer, G., Johnson, S., Yperman, M., Daemers, K., Offeciers, F.E., O'Donoghue, G.M., et al. 2003. Long-term evaluation of the effect of intracochlear steroid deposition on electrode impedance in cochlear implant patients. Otology & Neurotology, 24(5): 769–774. doi: 10.1097/00129492-200309000-00014
   PubMed Web of Science ®Google Scholar
• Dinh, C.T., Bas, E., Chan, S.S., Dinh, J.N., Vu, L., Van De Water, T.R. 2011. Dexamethasone treatment of tumor necrosis factor-alpha challenged organ of Corti explants activates nuclear factor kappa B signaling that induces changes in gene expression that favor hair cell survival. Neuroscience, 188(C): 157–167. doi: 10.1016/j.neuroscience.2011.04.061
   PubMed Web of Science ®Google Scholar
• Eastwood, H., Chang, A., Kel, G., Sly, D., Richardson, R., O'Leary, S.J. 2010. Round window delivery of dexamethasone ameliorates local and remote hearing loss produced by cochlear implantation into the second turn of the guinea pig cochlea. Hearing Research, 265(1–2): 25–29. doi: 10.1016/j.heares.2010.03.006
   PubMed Web of Science ®Google Scholar
• Enticott, J.C., Eastwood, H.T., Briggs, R.J., Dowell, R.C., O'Leary, S.J. 2011. Methylprednisolone applied directly to the round window reduces dizziness after cochlear implantation: a randomized clinical trial. Audiology and Neurotology, 16(5): 289–303. doi: 10.1159/000322137
   PubMed Web of Science ®Google Scholar
• Erichsen, S., Zuo, J., Curtis, L., Rarey, K., Hultcrantz, M. 1996. Na,K-ATPase alpha- and beta-isoforms in the developing cochlea of the mouse. Hearing Research, 100(1–2): 143–149. doi: 10.1016/0378-5955(96)00105-0
   PubMed Web of Science ®Google Scholar
• Erixon, E., Köbler, S., Rask-Andersen, H. 2012. Cochlear implantation and hearing preservation: results in 21 consecutively operated patients using the round window approach. Acta Oto-laryngologica, 132(9): 923–931. doi: 10.3109/00016489.2012.680198
   PubMed Web of Science ®Google Scholar
• Eshraghi, A.A., Gupta, C., Van De Water, T.R., Bohorquez, J.E., Garnham, C., Bas, E., Talamo, V.M. 2013. Molecular mechanisms involved in cochlear implantation trauma and the protection of hearing and auditory sensory cells by inhibition of c-Jun-N-terminal kinase signaling. The Laryngoscope, 123 Suppl. 1: S1–S14. doi: 10.1002/lary.23902
   PubMed Web of Science ®Google Scholar
• Franchimont, D., Galon, J., Gadina, M., Visconti, R., Zhou, Y., Aringer, M., et al. 2000. Inhibition of Th1 immune response by glucocorticoids: dexamethasone selectively inhibits IL-12-induced Stat4 phosphorylation in T lymphocytes. The Journal of Immunology, 164(4): 1768–1774. doi: 10.4049/jimmunol.164.4.1768
   PubMed Web of Science ®Google Scholar
• Fraysse, B., Dillier, N., Klenzner, T., Laszig, R., Manrique, M., Morera Perez, C., et al. 1998. Cochlear implants for adults obtaining marginal benefit from acoustic amplification: a European study. American Journal of Otolaryngology, 19(5): 591–577.
   Web of Science ®Google Scholar
• Fukushima, M., Kitahara, T., Fuse, Y., Uno, Y., Doi, K., Kubo, T. Changes in aquaporin expression in the inner ear of the rat after i.p. injection of steroids. Acta Otolaryngol Suppl, 2004 Aug;(553): 13–18. doi: 10.1080/03655230410017599
   PubMedGoogle Scholar
• Gallegos-Constantino, V.V., Cervera-Paz, F.J.F., Salvador, J.J., Ba, F.K.F., Perez-Fernandez, N.N. 2011. Hyperglycemia after intratympanic dexamethasone treatment in a diabetic patient. Revue de Laryngologie Otologie Rhinologie (Bord), 132(3): 153–155.
   PubMedGoogle Scholar
• Gametchu, B., Watson, C.S., Wu, S. 1993. Use of receptor antibodies to demonstrate membrane glucocorticoid receptor in cells from human leukemic patients. FASEB Journal, 7(13): 1283–1292.
   PubMed Web of Science ®Google Scholar
• Gantz, B.J., Hansen, M.R., Turner, C.W., Oleson, J.J., Reiss, L.A., Parkinson, A.J. 2009. Hybrid 10 clinical trial: preliminary results. Audiology and Neurotology, 14(Suppl. 1): 32–38. doi: 10.1159/000206493
   PubMed Web of Science ®Google Scholar
• Garavello, W., Galluzzi, F., Gaini, R.M., Zanetti, D. 2012. Intratympanic steroid treatment for sudden deafness: a meta-analysis of randomized controlled trials. Otology & Neurotology, 33(5): 724–729. doi: 10.1097/MAO.0b013e318254ee04
   PubMed Web of Science ®Google Scholar
• Gfeller, K.E., Olszewski, C., Turner, C., Gantz, B., Oleson, J. 2006. Music perception with cochlear implants and residual hearing. Audiology and Neurotology, 11(Suppl. 1): 12–15. doi: 10.1159/000095608
   PubMed Web of Science ®Google Scholar
• Gifford, R.H., Dorman, M.F., Skarzynski, H., Lorens, A., Polak, M., Driscoll, C.L., et al. 2013. Cochlear implantation with hearing preservation yields significant benefit for speech recognition in complex listening environments. Ear and Hearing, 34(4): 413–425. doi: 10.1097/AUD.0b013e31827e8163
   PubMed Web of Science ®Google Scholar
• Grewal, A.S., Nedzelski, J.M., Chen, J.M., Lin, V.Y. 2013. Dexamethasone uptake in the murine organ of Corti with transtympanic versus systemic administration. Journal of Otolaryngology – Head and Neck Surgery, 42: 19. doi: 10.1186/1916-0216-42-19
   Web of Science ®Google Scholar
• Gstoettner, W.K., Helbig, S., Maier, N., Kiefer, J., Radeloff, A., Adunka, O.F. 2006. Ipsilateral electric acoustic stimulation of the auditory system: results of long-term hearing preservation. Audiology and Neurotology, 11(Suppl. 1): 49–56. doi: 10.1159/000095614
   PubMedGoogle Scholar
• Gstoettner, W., Helbig, S., Settevendemie, C., Baumann, U., Wagenblast, J., Arnoldner, C. 2009. A new electrode for residual hearing preservation in cochlear implantation: first clinical results. Acta Otolaryngologica, 129(4): 372–379. doi: 10.1080/00016480802552568
   PubMed Web of Science ®Google Scholar
• Gstoettner, W., Kiefer, J., Baumgartner, W.D., Pok, S., Peters, S., Adunka, O. 2004. Hearing preservation in cochlear implantation for electric acoustic stimulation. Acta Otolaryngologica, 124(4): 348–352. doi: 10.1080/00016480410016432
   PubMed Web of Science ®Google Scholar
• Gurwitz, J.H., Bohn, R.L., Glynn, R.J., Monane, M., Mogun, H., Avorn, J. 1994. Glucocorticoids and the risk for initiation of hypoglycemic therapy. Archives of Internal Medicine, 154(1): 97–101. doi: 10.1001/archinte.1994.00420010131015
   PubMedGoogle Scholar
• Haake, S.M., Dinh, C.T., Chen, S., Eshraghi, A.A., Van De Water, T.R. 2009. Dexamethasone protects auditory hair cells against TNFalpha-initiated apoptosis via activation of PI3K/Akt and NFkappaB signaling. Hearing Research, 255(1–2): 22–32. doi: 10.1016/j.heares.2009.05.003
   PubMed Web of Science ®Google Scholar
• Hahn, H., Kammerer, B., DiMauro, A., Salt, A.N., Plontke, S.K. 2006. Cochlear microdialysis for quantification of dexamethasone and fluorescein entry into scala tympani during round window administration. Hearing Research, 212(1–2): 236–244. doi: 10.1016/j.heares.2005.12.001
   PubMed Web of Science ®Google Scholar
• Hahn, H., Salt, A.N., Biegner, T., Kammerer, B., Delabar, U., Hartsock, et al. 2012. Dexamethasone levels and base-to-apex concentration gradients in the scala tympani perilymph after intracochlear delivery in the guinea pig. Otology & Neurotology, 33(4): 660–665. doi: 10.1097/MAO.0b013e318254501b
   PubMed Web of Science ®Google Scholar
• Hamid, M., Trune, D. 2008. Issues, indications, and controversies regarding intratympanic steroid perfusion. Current Opinion in Otolaryngology & Head and Neck Surgery, 16(5): 434–440. doi: 10.1097/MOO.0b013e32830ce796
   PubMed Web of Science ®Google Scholar
• Hargunani, C.A., Kempton, J.B., DeGagne, J.M., Trune, D.R. 2006. Intratympanic injection of dexamethasone. Otology & Neurotology, 27(4): 564–569. doi: 10.1097/00129492-200606000-00021
   PubMed Web of Science ®Google Scholar
• Hashimoto, K., Seki, M., Miyasaka, H., Watanabe, K. 2006. Effect of steroids on increased permeability of blood vessels of the stria vascularis after auditory ossicle vibration by a drill in otologic surgery. Annals of Otology, Rhinology & Laryngology, 115(10): 769–774. doi: 10.1177/000348940611501010
   PubMed Web of Science ®Google Scholar
• Havenith, S., Versnel, H., Agterberg, M.J., de Groot, J.C., Sedee, R.J., Grolman, et al. 2011. Spiral ganglion cell survival after round window membrane application of brain-derived neurotrophic factor using gelfoam as carrier. Hearing Research, 272(1–2): 168–177. doi: 10.1016/j.heares.2010.10.003
   PubMed Web of Science ®Google Scholar
• Haynes, D.S., O'Malley, M., Cohen, S., Watford, K., Labadie RF. 2007. Intratympanic dexamethasone for sudden sensorineural hearing loss after failure of systemic therapy. The Laryngoscope, 117: 3–15. doi: 10.1097/01.mlg.0000245058.11866.15
   PubMed Web of Science ®Google Scholar
• Helbig, S.S., Baumann, U.U., Hey, C.C., Helbig, M.M. 2011. Hearing preservation after complete cochlear coverage in cochlear implantation with the free-fitting FLEXSOFT electrode carrier. Otology & Neurotology, 32(6): 973–979. doi: 10.1097/MAO.0b013e31822558c4
   PubMed Web of Science ®Google Scholar
• Hentzer, E. 1984. Ultra structure of the middle ear mucosa. Acta Otolaryngologica, 98: 19–27. doi: 10.3109/00016488409122876
   Google Scholar
• Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X.H., Briner, V.A. 2000. Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment. The Lancet, 355(9203): 542–545. doi: 10.1016/S0140-6736(99)06290-X
   PubMed Web of Science ®Google Scholar
• Herr, B.D., Marzo, S.J. 2005. Intratympanic steroid perfusion for refractory sudden sensorineural hearing loss. Otolaryngology – Head and Neck Surgery, 132: 527–531. doi: 10.1016/j.otohns.2004.09.138
   PubMed Web of Science ®Google Scholar
• Ho, G.M., Lin, H.G., Shu, M.T. 2004. Effectiveness of intratympanic dexamethasone injection in sudden deafness patients as salvage treatment. Laryngoscope, 114: 1184–1189. doi: 10.1097/00005537-200407000-00010
   PubMed Web of Science ®Google Scholar
• Hoang, K.N., Dinh, C.T., Bas, E., Chen, S., Eshraghi, A.A., Van De Water, T.R. 2009. Dexamethasone treatment of naïve organ of Corti explants alters the expression pattern of apoptosis-related genes. Brain Research, 1301(C): 1–8. doi: 10.1016/j.brainres.2009.08.097
   PubMed Web of Science ®Google Scholar
• Hochmair-Desoyer, I.J., Hochmair, E.S., Fischer, R.E., Burian, K. 1980. Cochlear prostheses in use: recent speech comprehension results. Archives of Otorhinolaryngology, 229(2): 81–98. doi: 10.1007/BF00454232
   PubMedGoogle Scholar
• Hogan, C.A., Turner, C.W. 1998. High-frequency audibility: benefits for hearing-impaired listeners. The Journal of the Acoustical Society of America, 104: 432–441. doi: 10.1121/1.423247
   PubMed Web of Science ®Google Scholar
• Hu, A., Parnes, L.S. 2009. Intratympanic steroids for inner ear disorders: a review. Audiology and Neurotology, 14: 373–382. doi: 10.1159/000241894
   PubMed Web of Science ®Google Scholar
• Huang, C.Q., Tykocinski, M., Stathopoulos, D., Cowan, R. 2007. Effects of steroids and lubricants on electrical impedance and tissue response following cochlear implantation. Cochlear Implants International, 8(3): 123–147. doi: 10.1179/cim.2007.8.3.123
   PubMedGoogle Scholar
• James, C., Albegger, K., Battmer, R., Burdo, S., Deggouj, N., Deguine, O., et al. 2005. Preservation of residual hearing with cochlear implantation: how and why. Acta Otolaryngologica, 125(5): 481–491. doi: 10.1080/00016480510026197
   PubMed Web of Science ®Google Scholar
• James, D.P., Eastwood, H., Richardson, R.T., O rsquo Leary, S.J. 2008. Effects of round window dexamethasone on residual hearing in a guinea pig model of cochlear implantation. Audiology and Neurotology, 13(2): 86–96. doi: 10.1159/000111780
   PubMed Web of Science ®Google Scholar
• Juhn, S.K., Hunter, B.A., Odland, R.M. 2001. Blood–labyrinth barrier and fluid dynamics of the inner ear. The International Tinnitus Journal, 7(2): 72–83.
   PubMedGoogle Scholar
• Kang, S.Y., Colesa, D.J., Swiderski, D.L., Su, G.L., Raphael, Y., Pfingst, B.E. 2010. Effects of hearing preservation on psychophysical responses to cochlear implant stimulation. Journal of the Association for Research in Otolaryngology, 11(2): 245–265. doi: 10.1007/s10162-009-0194-7
   PubMed Web of Science ®Google Scholar
• Kiefer, J., Gstoettner, W., Baumgartner, W., Pok, S.M., Tillein, J., Ye, et al. 2004. Conservation of low-frequency hearing in cochlear implantation. Acta Otolaryngologica, 124(3): 272–80. doi: 10.1080/00016480310000755a
   PubMed Web of Science ®Google Scholar
• Kiefer, J., Pok, M., Adunka, O., Stürzebecher, E., Baumgartner, W., Schmidt, M., et al. 2005. Combined electric and acoustic stimulation of the auditory system: results of a clinical study. Audiology and Neurotology, 10: 134–144. doi: 10.1159/000084023
   PubMed Web of Science ®Google Scholar
• Kontorinis, G., Lenarz, T., Stöver, T., Paasche, G. 2011. Impact of the insertion speed of cochlear implant electrodes on the insertion forces. Otology & Neurotology, 32(4): 565–570. doi: 10.1097/MAO.0b013e318219f6ac
   PubMed Web of Science ®Google Scholar
• Kopelovich, J.C., Reiss, L.A., Oleson, J.J., Lundt, E.S., Gantz, B.J., Hansen, M.R. 2014. Risk factors for loss of ipsilateral residual hearing after hybrid cochlear implantation. Otology & Neurotology, 35(8): 1403–1408. doi: 10.1097/MAO.0000000000000389
   PubMed Web of Science ®Google Scholar
• Kopke, R.D., Hoffer, M.E., Wester, D., O'Leary, M.J., Jackson, R.L. 2001. Targeted topical steroid therapy in sudden sensorineural hearing loss. Otology & Neurotology, 22: 475–479. doi: 10.1097/00129492-200107000-00011
   PubMed Web of Science ®Google Scholar
• Kuthubutheen, J., Coates, H., Rowsell, C., Nedzelski, J., Chen, J.M., Lin, V. 2015. The role of extended preoperative steroids in hearing preservation cochlear implantation. Hear Res. Sep;327:257–64.
   PubMed Web of Science ®Google Scholar
• Kuthubutheen, J., Hedne, C.N., Krishnaswamy, J., Rajan, G.P. 2012. A case series of paediatric hearing preservation cochlear implantation: a new treatment modality for children with drug-induced or congenital partial deafness. Audiology and Neurotology, 17(5): 321–330. doi: 10.1159/000339350
   PubMed Web of Science ®Google Scholar
• van der Laan, S., Meijer, O.C. 2008. Pharmacology of glucocorticoids: beyond receptors. European Journal of Pharmacology, 585(2–3): 483–491. doi: 10.1016/j.ejphar.2008.01.060
   PubMed Web of Science ®Google Scholar
• Lalwani, A.K., Walsh, B.J., Reilly, P.G., Muzyczka, N., Mhatre, A.N. 1996. Development of in vivo gene therapy for hearing disorders: introduction of adeno-associated virus into the cochlea of the guinea pig. Gene Theraphy, 3(7): 588–92.
   PubMed Web of Science ®Google Scholar
• Lee, J., Ismail, H., Lee, J.H., Kel, G., O'Leary, J., Hampson, A., et al. 2013. Effect of both local and systemically administered dexamethasone on long-term hearing and tissue response in a Guinea pig model of cochlear implantation. Audiology and Neurotology, 18(6): 392–405. doi: 10.1159/000353582
   PubMed Web of Science ®Google Scholar
• Lee, J.H., Marcus, D.C. 2002. Nongenomic effects of corticosteroids on ion transport by stria vascularis. Audiology and Neuro-Otology, 7: 100–106. doi: 10.1159/000057657
   PubMed Web of Science ®Google Scholar
• Lefebvre, P.P., Staecker, H. 2002. Steroid perfusion of the inner ear for sudden sensorineural hearing loss after failure of conventional therapy: a pilot study. Acta Oto-Laryngologica, 122: 698–702. doi: 10.1080/003655402/000028037
   PubMed Web of Science ®Google Scholar
• Lenhardt, E. 1993. Intracochlear electrode placement facilitated by healon. In: Fraysse, B., Deguine, (eds.) Cochlear implants: new perspectives. Vol. 48. Basel: Karger, p. 62–4.
   Google Scholar
• Lin, F.R., Chien, W.W., Li, L., Clarrett, D.M., Niparko, J.K., Francis, H.W. 2012. Cochlear implantation in older adults. Medicine, 91(5): 229–241. doi: 10.1097/MD.0b013e31826b145a
   PubMed Web of Science ®Google Scholar
• Liu, H.J., Dong, M.M., Chi, F.L. 2006. Dexamethasone pharmacokinetics in Guinea pig inner ear perilymph. ORL journal for Oto-Rhino-Laryngology and its Related Specialties, 68(2): 93–98. doi: 10.1159/000091210
   PubMed Web of Science ®Google Scholar
• Lösel, R., Wehling, M. 2003. Nongenomic actions of steroid hormones. Nature Reviews Molecular Cell Biology, 4(1): 46–55. Review. doi: 10.1038/nrm1009
   PubMed Web of Science ®Google Scholar
• Löwenberg, M., Stahn, C., Hommes, D.W., Buttgereit, F. 2008. Novel insights into mechanisms of glucocorticoid action and the development of new glucocorticoid receptor ligands. Steroids, 73(9–10): 1025–1029. doi: 10.1016/j.steroids.2007.12.002
   PubMed Web of Science ®Google Scholar
• Lu, L., Dai, Y., Du, X., She, W., Zhang, X., Wu, et al. 2013. Relationship of glucocorticoid receptor expression in peripheral blood mononuclear cells and the cochlea of guinea pigs and effects of dexamethasone administration. PLoS ONE, 8(2): e56323. doi: 10.1371/journal.pone.0056323
   Google Scholar
• Maeda, Y., Fukushima, K., Hirai, M., Kariya, S., Smith, R.J.H., Nishizaki, K. 2010. Microarray analysis of the effect of dexamethasone on murine cochlear explants. Acta Oto-Laryngologica, 130(12): 1329–1334. doi: 10.3109/00016489.2010.498836
   PubMed Web of Science ®Google Scholar
• Maini, S., Lisnichuk, H., Eastwood, H., Pinder, D., James, D., Richardson, R.T., et al. 2009. Targeted therapy of the inner ear. Audiology and Neurotology, 14(6): 402–410. doi: 10.1159/000241897
   PubMed Web of Science ®Google Scholar
• Meyer, H., Stöver, T., Fouchet, F., Bastiat, G., Saulnier, P., Bäumer, W., et al. 2012. Lipidic nanocapsule drug delivery: neuronal protection for cochlear implant optimization. International Journal of Nanomedicine, 7: 2449–2464.
   PubMed Web of Science ®Google Scholar
• Mikulec, A.A., Hartsock, J.J., Salt, A.N. 2008. Permeability of the round window membrane is influenced by the composition of applied drug solutions and by common surgical procedures. Otology & Neurotology, 29(7): 1020–1026. doi: 10.1097/MAO.0b013e31818658ea
   PubMed Web of Science ®Google Scholar
• Mikulec, A.A., Plontke, S.K., Hartsock, J.J., Salt, A.N. 2009. Entry of substances into perilymph through the bone of the otic capsule after intratympanic applications in guinea pigs. Otology & Neurotology, 30(2): 131–138. doi: 10.1097/MAO.0b013e318191bff8
   PubMed Web of Science ®Google Scholar
• Miller, J.M., Chi, D.H., O'Keeffe, L.J., Kruszka, P., Raphael, Y., Altschuler, R.A. 1997. Neurotrophins can enhance spiral ganglion cell survival after inner hair cell loss. International Journal of Developmental Neuroscience, 15(4–5): 631–643. doi: 10.1016/S0736-5748(96)00117-7
   PubMed Web of Science ®Google Scholar
• Moghadam-Kia, S., Werth, V.P. 2010. Prevention and treatment of systemic glucocorticoid side effects. International Journal of Dermatology, 49(3): 239–248. doi: 10.1111/j.1365-4632.2009.04322.x
   PubMed Web of Science ®Google Scholar
• Mohammadpour, A. 2011. Morphometrical study of the temporal bone and auditory ossicles in guinea pig. Veterinary Research Forum, 2(1): 7–12.
   Google Scholar
• Murphy, D., Daniel, S.J. 2011. Intratympanic dexamethasone to prevent cisplatin ototoxicity: a guinea pig model. Otolaryngology – Head and Neck Surgery, 145(3): 452–457. doi: 10.1177/0194599811406673
   PubMed Web of Science ®Google Scholar
• Nadol JB Jr, Eddington, D.K. 2006. Histopathology of the inner ear relevant to cochlear implantation. Advances in Otorhinolaryngology, 64: 31–49.
   PubMedGoogle Scholar
• Nakashima, T., Hattori, T., Sone, M., Sato, E., Tominaga, M. 2002. Blood flow measurements in the ears of patients receiving cochlear implants. Annals of Otology, Rhinology & Laryngology, 111(11): 998–1001. doi: 10.1177/000348940211101108
   PubMed Web of Science ®Google Scholar
• Nordang, L., Linder, B., Anniko, M. 2003. Morphologic changes in round window membrane after topical hydrocortisone and dexamethasone treatment. Otology & Neurotology, 24: 339–343. doi: 10.1097/00129492-200303000-00034
   PubMed Web of Science ®Google Scholar
• O'Leary, S.J., Monksfield, P., Kel, G., Connolly, T., Souter, M.A., Chang, A., et al. 2013. Relations between cochlear histopathology and hearing loss in experimental cochlear implantation. Hearing Research, 298: 27–35. doi: 10.1016/j.heares.2013.01.012
   PubMed Web of Science ®Google Scholar
• Paasche, G., Bockel, F., Tasche, C., Lesinski-Schiedat, A., Lenarz, T. 2006. Changes of postoperative impedances in cochlear implant patients: the short-term effects of modified electrode surfaces and intracochlear corticosteroids. Otology & Neurotology, 27(5): 639–647. doi: 10.1097/01.mao.0000227662.88840.61
   PubMed Web of Science ®Google Scholar
• Paasche, G., Tasche, C., Stöver, T., Lesinski-Schiedat, A., Lenarz, T. 2009. The long-term effects of modified electrode surfaces and intracochlear corticosteroids on postoperative impedances in cochlear implant patients. Otology & Neurotology, 30(5): 592–598. doi: 10.1097/MAO.0b013e3181ab8fba
   PubMed Web of Science ®Google Scholar
• Parnes, L.S., Sun, A.H., Freeman, D.J. 1999. Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application. Laryngoscope, 109(7 Pt 2): 1–17. doi: 10.1097/00005537-199907001-00001
   PubMed Web of Science ®Google Scholar
• Pitovski, D.Z., Drescher, M.J., Drescher, D.G. 1994. Glucocorticoid receptors in the mammalian inner ear: RU 28362 binding sites. Hearing Research, 77(1–2): 216–220. doi: 10.1016/0378-5955(94)90269-0
   PubMed Web of Science ®Google Scholar
• Piu, F., Wang, X., Fernandez, R., Dellamary, L., Harrop, A., Ye, Q., et al. 2011. OTO-104: a sustained-release dexamethasone hydrogel for the treatment of otic disorders. Otology & Neurotology, 32(1): 171–179. doi: 10.1097/MAO.0b013e3182009d29
   PubMed Web of Science ®Google Scholar
• Plontke, S.K., Biegner, T., Kammerer, B., Delabar, U., Salt, A.N. 2008. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otology & Neurotology, 29(3): 401–406. doi: 10.1097/MAO.0b013e318161aaae
   PubMed Web of Science ®Google Scholar
• Plontke, S.K., Siedow, N., Wegener, R., Zenner, H.P., Salt, A.N. 2007. Cochlear pharmacokinetics with local inner ear drug delivery using a three-dimensional finite-element computer model. Audiology and Neurotology, 12: 37–48. doi: 10.1159/000097246
   PubMed Web of Science ®Google Scholar
• Pondugula, S.R., Raveendran, N.N., Ergonul, Z., Deng, Y., Chen, J., Sanneman, J.D., et al. 2006. Glucocorticoid regulation of genes in the amiloride-sensitive sodium transport pathway by semicircular canal duct epithelium of neonatal rat. Physiological Genomics, 24(2): 114–123. doi: 10.1152/physiolgenomics.00006.2005
   PubMed Web of Science ®Google Scholar
• Punte, A.K., Vermeire, K., Van de Heyning, P. 2010. Bilateral electric acoustic stimulation: a comparison of partial and deep cochlear electrode insertion. A longitudinal case study. Advances in Otorhinolaryngology, 67: 144–152.
   PubMedGoogle Scholar
• Quesnel, S., Nguyen, Y., Elmaleh, M., Grayeli, A.B., Ferrary, E., Sterkers, O., et al. 2011. Effects of systemic administration of methylprednisolone on residual hearing in an animal model of cochlear implantation. Acta Oto-laryngologica, 131(6): 579–584. doi: 10.3109/00016489.2010.541936
   PubMed Web of Science ®Google Scholar
• Rajan, G.P., Kuthubutheen, J., Hedne, N., Krishnaswamy, J. 2012. The role of preoperative, intratympanic glucocorticoids for hearing preservation in cochlear implantation: a prospective clinical study. The Laryngoscope, 122(1): 190–195. doi: 10.1002/lary.22142
   PubMed Web of Science ®Google Scholar
• Rarey, K.E., Curtis, L.M. 1996. Receptors for glucocorticoids in the human inner ear. Otolaryngology – Head and Neck Surgery, 115(1): 38–41. doi: 10.1016/S0194-5998(96)70133-X
   PubMed Web of Science ®Google Scholar
• Rifai, K., Kirchner, G.I., Bahr, M.J., Cantz, T., Rosenau, J., Nashan, B., et al. 2006. A new side effect of immunosuppression: high incidence of hearing impairment after liver transplantation. Liver Transplantation, 12(3): 411–415. doi: 10.1002/lt.20610
   PubMed Web of Science ®Google Scholar
• Romano, S., D'Angelillo, A., Pacelli, R., Staibano, S., De Luna, E., Bisogni, R., et al. 2010. Role of FK506-binding protein 51 in the control of apoptosis of irradiated melanoma cells. Cell Death and Differentiation, 17(1): 145–157. doi: 10.1038/cdd.2009.115
   PubMed Web of Science ®Google Scholar
• Saag, K.G., Furst, D.E. 2013. Major side effects of systemic glucocorticoids Up To Date2012; 2013. http://www.uptodate.com/contents/major-side-effects-of-systemic-glucocorticoids│
   Google Scholar
• Salt, A.N., Hartsock, J., Plontke, S., LeBel, C., Piu, F. 2011. Distribution of dexamethasone and preservation of inner ear function following intratympanic delivery of a gel-based formulation. Audiology and Neurotology, 16(5): 323–335. doi: 10.1159/000322504
   PubMed Web of Science ®Google Scholar
• Salt, A.N., Plontke, S.K. 2009. Principles of local drug delivery to the inner ear. Audiology and Neurotology, 14(6): 350–360. doi: 10.1159/000241892
   PubMed Web of Science ®Google Scholar
• Santa Maria, P.L., Domville-Lewis, C., Sucher, C.M., Chester-Browne, R., Atlas, M.D. 2013. Hearing preservation surgery for cochlear implantation – hearing and quality of life after 2 years. Otology & Neurotology, 34(3): 526–531. doi: 10.1097/MAO.0b013e318281e0c9
   PubMed Web of Science ®Google Scholar
• Santa Maria, P.L., Gluth, M.B., Yuan, Y., Atlas, M.D., Blevins, N.H. 2014. Hearing preservation surgery for cochlear implantation: a meta-analysis. Otology & Neurotology, 35(10): e256–e269. doi: 10.1097/MAO.0000000000000561
   PubMed Web of Science ®Google Scholar
• Schneiter, P., Tappy, L. 1998. Kinetics of dexamethasone-induced alterations of glucose metabolism in healthy humans. American Journal of Physiology, 275(5 Pt 1): E806–E813.
   PubMed Web of Science ®Google Scholar
• Shirwany, N.A., Seidman, M.D., Tang, W. 1998. Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig. The American journal of Otology, 19(2): 230–235.
   PubMedGoogle Scholar
• Silverstein, H., Choo, D., Rosenberg, S.I., Kuhn, J., Seidman, M., Stein, I. 1996. Intratympanic steroid treatment of inner ear disease and tinnitus (preliminary report). Ear Nose & Throat Journal, 75(8): 468–471.
   PubMedGoogle Scholar
• Skarzynski, H., Lorens, A., Matusiak, M., Porowski, M., Skarzynski, P.H., James, C.J. 2012. Partial deafness treatment with the nucleus straight research array cochlear implant. Audiology and Neurotology, 17(2): 82–91. doi: 10.1159/000329366
   PubMed Web of Science ®Google Scholar
• Slattery, W.H., Fisher, L.M., Iqbal, Z., Friedman, R.A., Liu, N. 2005. Intra- tympanic steroid for the treatment of sudden hearing loss. Otolaryngology – Head and Neck Surgery, 133: 251–259. doi: 10.1016/j.otohns.2005.05.015
   PubMed Web of Science ®Google Scholar
• Souter, M., Eastwood, H., Marovic, P., Kel, G., Wongprasartsuk, S., Ryan, A.F., et al. 2012. Systemic immunity influences hearing preservation in cochlear implantation. Otology and Neurotology, 33(4): 532–538. doi: 10.1097/MAO.0b013e31824bac44
   PubMed Web of Science ®Google Scholar
• Spandow, O., Anniko, M., Hellstrom, S. 1989. Hydrocortisone applied to the round window niche causes electrophysiological dysfunction of the inner ear. Journal of Otorhinolaryngology, 51: 94–102.
   Google Scholar
• Sterkers, O., Ferrary, E., Saumon, G., Amiel, C. 1987. Na and nonelectrolyte entry intoinner ear fluids of the rat. American Journal of Physiology, 253(1 Pt 2): F50–F58.
   PubMed Web of Science ®Google Scholar
• Strupp, M., Zingler, V.C., Arbusow, V., Niklas, D., Maag, K.P., Dieterich, M., et al. 2004. Methylprednisolone, valacyclovir, or the combination for vestibular neuritis. New England Journal of Medicine, 351: 354–361. doi: 10.1056/NEJMoa033280
   PubMed Web of Science ®Google Scholar
• Tailor, A., Tomlinson, A., Salas, A., Panes, J., Granger, D.N., Flower, R.J., et al. 1999. Dexamethasone inhibition of leucocyte adhesion to rat mesenteric postcapillary venules: role of intercellular adhesion molecule 1 and KC. Gut, 45: 705–712. doi: 10.1136/gut.45.5.705
   PubMed Web of Science ®Google Scholar
• Takemura, K., Komeda, M., Yagi, M., Himeno, C., Izumikawa, M., Doi, T., et al. 2004. Direct inner ear infusion of dexamethasone attenuates noise-induced trauma in guinea pig. Hearing Research, 196(1–2): 58–68. doi: 10.1016/j.heares.2004.06.003
   PubMed Web of Science ®Google Scholar
• Tamir, S., Ferrary, E., Borel, S., Sterkers, O., Bozorg Grayeli, A. 2012. Hearing preservation after cochlear implantation using deeply inserted flex atraumatic electrode arrays. Audiology and Neurotology, 17(5): 331–337. doi: 10.1159/000339894
   PubMed Web of Science ®Google Scholar
• Tanaka, H., Hirano, F., Nomura, Y., Miura, T., Makino, Y., Fukawa, E., et al. 1994. Relative glucocorticoid potency revisited. Rheumatology International, 14: 9–12. doi: 10.1007/BF00302665
   PubMed Web of Science ®Google Scholar
• Tanaka, C., Nguyen-Huynh, A., Loera, K., Stark, G., Reiss, L. 2014. Factors associated with hearing loss in a normal-hearing guinea pig model of Hybrid cochlear implants. Hearing Research, 316: 82–93. doi: 10.1016/j.heares.2014.07.011
   PubMed Web of Science ®Google Scholar
• ten Cate, W.J., Curtis, L.M., Small, G.M., Rarey, K.E. 1993. Localization of glucocorticoid receptors and glucocorticoid receptor mRNAs in the rat cochlea. The Laryngoscope, 103(8): 865–871. doi: 10.1288/00005537-199308000-00007
   PubMed Web of Science ®Google Scholar
• Tobita, T., Senarita, M., Hara, A., Kusakari, J. 2002. Determination of prednisolone in the cochlear tissue. Hearing Research, 165(1–2): 30–34. doi: 10.1016/S0378-5955(01)00394-X
   PubMed Web of Science ®Google Scholar
• Trune, D.R., Kempton, J.B., Gross, N.D. 2006. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear. Hearing Research, 212: 22–32. doi: 10.1016/j.heares.2005.10.006
   PubMed Web of Science ®Google Scholar
• Trune, D.R., Kempton, J.B., Harrison, A.R., Wobig, J.L. 2007. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice. Hearing Research, 226: 209–217. doi: 10.1016/j.heares.2006.09.011
   PubMed Web of Science ®Google Scholar
• Turner, R., Elson, E. 1993. Sleep disorders. Steroids cause sleep disturbance. BMJ, 306(6890): 1477–8. doi: 10.1136/bmj.306.6890.1477-d
   PubMed Web of Science ®Google Scholar
• Usami, S., Moteki, H., Suzuki, N., Fukuoka, H., Miyagawa, M., Nishio, et al. 2011. Achievement of hearing preservation in the presence of an electrode covering the residual hearing region. Acta Oto-laryngologica, 131(4): 405–412. doi: 10.3109/00016489.2010.539266
   PubMed Web of Science ®Google Scholar
• Wang, X., Dellamary, L., Fernandez, R., Harrop, A., Keithley, E.M., Harris, J.P., et al. 2009. Dose-dependent sustained release of dexamethasone in inner ear cochlear fluids using a novel local delivery approach. Audiology and Neurotology, 14(6): 393–401. doi: 10.1159/000241896
   PubMed Web of Science ®Google Scholar
• Wang, X., Dellamary, L., Fernandez, R., Ye, Q., LeBel, C., Piu, F. 2011a. Principles of inner ear sustained release following intratympanic administration. The Laryngoscope, 121(2): 385–391. doi: 10.1002/lary.21370
   PubMed Web of Science ®Google Scholar
• Wang, X., Fernandez, R., Dellamary, L., Harrop, A., Ye, Q., Lichter, et al. 2011b. Pharmacokinetics of dexamethasone solution following intratympanic injection in guinea pig and sheep. Audiology and Neurotology, 16(4): 233–241. doi: 10.1159/000320611
   PubMed Web of Science ®Google Scholar
• Wei, L., MacDonald, T.M., Walker, B.R. 2004. Taking glucocorticoids by prescription is associated with subsequent cardiovascular disease. Annals of Internal Medicine, 141(10): 764–70. doi: 10.7326/0003-4819-141-10-200411160-00007
   PubMed Web of Science ®Google Scholar
• Weinstein, R.S. 2012. Glucocorticoid-induced osteonecrosis. Endocrine, 41(2): 183–190. doi: 10.1007/s12020-011-9580-0
   PubMed Web of Science ®Google Scholar
• Wilson, B.S., Dorman, M.F. 2008. Cochlear implants: current designs and future possibilities. The Journal of Rehabilitation Research and Development, 45(5): 695–730. doi: 10.1682/JRRD.2007.10.0173
   PubMed Web of Science ®Google Scholar
• Wilson, B.S., Lawson, D.T., Muller, J.M., Tyler, R.S., Kiefer, J. 2003. Cochlear implants: some likely next steps. Annual Review of Biomedical Engineering, 5: 207–249. doi: 10.1146/annurev.bioeng.5.040202.121645
   PubMed Web of Science ®Google Scholar
• Worsøe, L., Brandt, C.T., Lund, S.P., Ostergaard, C., Thomsen, J., Cayé-Thomasen, P. 2010. Intratympanic steroid prevents long-term spiral ganglion neuron loss in experimental meningitis. Otology & Neurotology, 31(3): 394–403. doi: 10.1097/MAO.0b013e3181d2796c
   PubMed Web of Science ®Google Scholar
• Wright, C.G., Roland, P.S. 2013. Vascular trauma during cochlear implantation Otology & Neurotology, 34(3): 402–407. doi: 10.1097/MAO.0b013e318278509a
   PubMed Web of Science ®Google Scholar
• Ye, Q., Tillein, J., Hartmann, R., Gstoettner, W., Kiefer, J. 2007. Application of a corticosteroid (Triamcinolon) protects inner ear function after surgical intervention. Ear and Hearing, 28(3): 361–369. doi: 10.1097/01.aud.0000261655.30652.62
   PubMed Web of Science ®Google Scholar
• Zuo, J., Curtis, L.M., Yao, X., ten Cate, W.J., Bagger-Sjöbäck, D., Hultcrantz, et al. 1995. Glucocorticoid receptor expression in the postnatal rat cochlea. Hearing Research, 87(1–2): 220–227. doi: 10.1016/0378-5955(95)00092-I
   PubMed Web of Science ®Google Scholar